A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord

Shinjiro Kaneko, Akio Iwanami, Masaya Nakamura, Akiyoshi Kishino, Kaoru Kikuchi, Shinsuke Shibata, Hirotaka J. Okano, Takeshi Ikegami, Ayako Moriya, Osamu Konishi, Chikao Nakayama, Kazuo Kumagai, Toru Kimura, Yasufumi Sato, Yoshio Goshima, Masahiko Taniguchi, Mamoru Ito, Zhigang He, Yoshiaki Toyama, Hideyuki Okano

Research output: Contribution to journalArticle

272 Citations (Scopus)

Abstract

Axons in the adult mammalian central nervous system (CNS) exhibit little regeneration after injury. It has been suggested that several axonal growth inhibitors prevent CNS axonal regeneration. Recent research has demonstrated that semaphorin3A (Sema3A) is one of the major inhibitors of axonal regeneration. We identified a strong and selective inhibitor of Sema3A, SM-216289, from the fermentation broth of a fungal strain. To examine the effect of SM-216289 in vivo, we transected the spinal cord of adult rats and administered SM-216289 into the lesion site for 4 weeks. Rats treated with SM-216289 showed substantially enhanced regeneration and/or preservation of injured axons, robust Schwann cell-mediated myelination and axonal regeneration in the lesion site, appreciable decreases in apoptotic cell number and marked enhancement of angiogenesis, resulting in considerably better functional recovery. Thus, Sema3A is essential for the inhibition of axonal regeneration and other regenerative responses after spinal cord injury (SCI). These results support the possibility of using Sema3A inhibitors in the treatment of human SCI.

Original languageEnglish
Pages (from-to)1380-1389
Number of pages10
JournalNature Medicine
Volume12
Issue number12
DOIs
Publication statusPublished - 2006 Dec

Fingerprint

Regeneration
Spinal Cord
Recovery
Neurology
Rats
Cells
Spinal Cord Injuries
Growth Inhibitors
Axons
Central Nervous System
Fermentation
Schwann Cells
xanthofulvin
Cell Count
Wounds and Injuries
Research

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. / Kaneko, Shinjiro; Iwanami, Akio; Nakamura, Masaya; Kishino, Akiyoshi; Kikuchi, Kaoru; Shibata, Shinsuke; Okano, Hirotaka J.; Ikegami, Takeshi; Moriya, Ayako; Konishi, Osamu; Nakayama, Chikao; Kumagai, Kazuo; Kimura, Toru; Sato, Yasufumi; Goshima, Yoshio; Taniguchi, Masahiko; Ito, Mamoru; He, Zhigang; Toyama, Yoshiaki; Okano, Hideyuki.

In: Nature Medicine, Vol. 12, No. 12, 12.2006, p. 1380-1389.

Research output: Contribution to journalArticle

Kaneko, S, Iwanami, A, Nakamura, M, Kishino, A, Kikuchi, K, Shibata, S, Okano, HJ, Ikegami, T, Moriya, A, Konishi, O, Nakayama, C, Kumagai, K, Kimura, T, Sato, Y, Goshima, Y, Taniguchi, M, Ito, M, He, Z, Toyama, Y & Okano, H 2006, 'A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord', Nature Medicine, vol. 12, no. 12, pp. 1380-1389. https://doi.org/10.1038/nm1505
Kaneko, Shinjiro ; Iwanami, Akio ; Nakamura, Masaya ; Kishino, Akiyoshi ; Kikuchi, Kaoru ; Shibata, Shinsuke ; Okano, Hirotaka J. ; Ikegami, Takeshi ; Moriya, Ayako ; Konishi, Osamu ; Nakayama, Chikao ; Kumagai, Kazuo ; Kimura, Toru ; Sato, Yasufumi ; Goshima, Yoshio ; Taniguchi, Masahiko ; Ito, Mamoru ; He, Zhigang ; Toyama, Yoshiaki ; Okano, Hideyuki. / A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. In: Nature Medicine. 2006 ; Vol. 12, No. 12. pp. 1380-1389.
@article{237b423264c24e7cb89662e007a8d178,
title = "A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord",
abstract = "Axons in the adult mammalian central nervous system (CNS) exhibit little regeneration after injury. It has been suggested that several axonal growth inhibitors prevent CNS axonal regeneration. Recent research has demonstrated that semaphorin3A (Sema3A) is one of the major inhibitors of axonal regeneration. We identified a strong and selective inhibitor of Sema3A, SM-216289, from the fermentation broth of a fungal strain. To examine the effect of SM-216289 in vivo, we transected the spinal cord of adult rats and administered SM-216289 into the lesion site for 4 weeks. Rats treated with SM-216289 showed substantially enhanced regeneration and/or preservation of injured axons, robust Schwann cell-mediated myelination and axonal regeneration in the lesion site, appreciable decreases in apoptotic cell number and marked enhancement of angiogenesis, resulting in considerably better functional recovery. Thus, Sema3A is essential for the inhibition of axonal regeneration and other regenerative responses after spinal cord injury (SCI). These results support the possibility of using Sema3A inhibitors in the treatment of human SCI.",
author = "Shinjiro Kaneko and Akio Iwanami and Masaya Nakamura and Akiyoshi Kishino and Kaoru Kikuchi and Shinsuke Shibata and Okano, {Hirotaka J.} and Takeshi Ikegami and Ayako Moriya and Osamu Konishi and Chikao Nakayama and Kazuo Kumagai and Toru Kimura and Yasufumi Sato and Yoshio Goshima and Masahiko Taniguchi and Mamoru Ito and Zhigang He and Yoshiaki Toyama and Hideyuki Okano",
year = "2006",
month = "12",
doi = "10.1038/nm1505",
language = "English",
volume = "12",
pages = "1380--1389",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord

AU - Kaneko, Shinjiro

AU - Iwanami, Akio

AU - Nakamura, Masaya

AU - Kishino, Akiyoshi

AU - Kikuchi, Kaoru

AU - Shibata, Shinsuke

AU - Okano, Hirotaka J.

AU - Ikegami, Takeshi

AU - Moriya, Ayako

AU - Konishi, Osamu

AU - Nakayama, Chikao

AU - Kumagai, Kazuo

AU - Kimura, Toru

AU - Sato, Yasufumi

AU - Goshima, Yoshio

AU - Taniguchi, Masahiko

AU - Ito, Mamoru

AU - He, Zhigang

AU - Toyama, Yoshiaki

AU - Okano, Hideyuki

PY - 2006/12

Y1 - 2006/12

N2 - Axons in the adult mammalian central nervous system (CNS) exhibit little regeneration after injury. It has been suggested that several axonal growth inhibitors prevent CNS axonal regeneration. Recent research has demonstrated that semaphorin3A (Sema3A) is one of the major inhibitors of axonal regeneration. We identified a strong and selective inhibitor of Sema3A, SM-216289, from the fermentation broth of a fungal strain. To examine the effect of SM-216289 in vivo, we transected the spinal cord of adult rats and administered SM-216289 into the lesion site for 4 weeks. Rats treated with SM-216289 showed substantially enhanced regeneration and/or preservation of injured axons, robust Schwann cell-mediated myelination and axonal regeneration in the lesion site, appreciable decreases in apoptotic cell number and marked enhancement of angiogenesis, resulting in considerably better functional recovery. Thus, Sema3A is essential for the inhibition of axonal regeneration and other regenerative responses after spinal cord injury (SCI). These results support the possibility of using Sema3A inhibitors in the treatment of human SCI.

AB - Axons in the adult mammalian central nervous system (CNS) exhibit little regeneration after injury. It has been suggested that several axonal growth inhibitors prevent CNS axonal regeneration. Recent research has demonstrated that semaphorin3A (Sema3A) is one of the major inhibitors of axonal regeneration. We identified a strong and selective inhibitor of Sema3A, SM-216289, from the fermentation broth of a fungal strain. To examine the effect of SM-216289 in vivo, we transected the spinal cord of adult rats and administered SM-216289 into the lesion site for 4 weeks. Rats treated with SM-216289 showed substantially enhanced regeneration and/or preservation of injured axons, robust Schwann cell-mediated myelination and axonal regeneration in the lesion site, appreciable decreases in apoptotic cell number and marked enhancement of angiogenesis, resulting in considerably better functional recovery. Thus, Sema3A is essential for the inhibition of axonal regeneration and other regenerative responses after spinal cord injury (SCI). These results support the possibility of using Sema3A inhibitors in the treatment of human SCI.

UR - http://www.scopus.com/inward/record.url?scp=33845530894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845530894&partnerID=8YFLogxK

U2 - 10.1038/nm1505

DO - 10.1038/nm1505

M3 - Article

C2 - 17099709

AN - SCOPUS:33845530894

VL - 12

SP - 1380

EP - 1389

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 12

ER -